Table 5.
Results from a negative binomial regression model to estimate hospital days
| Variable | IRR | P | 95% CI |
|---|---|---|---|
| Ivabradine | 1.63 | 0.187 | 0.79-3.38 |
| Ethnicity (non-Arab) | 0.45 | 0.015 | 0.23-0.86 |
| BMI | 1.035 | 0.301 | 0.97-1.10 |
| HR | 0.94 | 0.003 | 0.91-0.98 |
| SBP | 1.00 | 0.997 | 0.98-1.03 |
| DBP | 1.02 | 0.273 | 0.99-1.05 |
| LVEF overall | |||
| 25-30 | 0.59 | 0.225 | 0.25-1.38 |
| 30-35 | 0.25 | 0.007 | 0.09-0.68 |
| 35-40 | 0.47 | 0.124 | 0.18-1.23 |
| Etiology (ischemic) | 3.01 | 0.005 | 1.40-6.45 |
| DM | 1.05 | 0.879 | 0.55-2.01 |
| MI | 0.98 | 0.952 | 0.45-2.12 |
| ACE or ARB | |||
| ACE | 0.48 | 0.240 | 0.14-1.65 |
| ARB | 0.46 | 0.269 | 0.11-1.83 |
| ARNI overall (mg BID) | |||
| 100 | 0.19 | 0.040 0.219 |
0.01-2.65 |
| 50 | 0.07 | 0.029 | 0.01-0.76 |
IRR: Incidence rate ratio, CI: Confidence interval, DM: Diabetes mellitus, BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, LVEF: Left ventricular ejection fraction, MI: Myocardial infarction, ACE: Angiotensin-converting enzyme, ARB: Angiotensin receptor blocker, ARNI: Angiotensin receptor neprilysin inhibitor, HR: Heart rate, BID: Twice daily